- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by VUNO
Total 33 results
-
CelgeneJunoWithdrawnPrecursor Cell Lymphoblastic Leukemia-LymphomaBelgium, France, Spain, Italy, Germany, Switzerland, United Kingdom
-
Juno Therapeutics, a Subsidiary of CelgeneRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small LymphocyticUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedMultiple MyelomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedAcute Lymphoblastic LeukemiaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneTerminatedAcute Lymphoblastic LeukemiaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingMultiple MyelomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
Juno Therapeutics, a Subsidiary of CelgeneTerminatedFollicular Lymphoma | Multiple Myeloma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingFollicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, NonhodgkinUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneAvailableLymphoma, Large B-Cell, Diffuse
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Nuno MoraisInstituto Politécnico de LeiriaCompletedOther Lesions of Median NervePortugal
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Recruiting
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers SquibbCompletedNeoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System DisorderUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIA; Juno Therapeutics, Inc.Not yet recruiting
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Adult Acute Lymphoblastic Leukemia | Refractory Diffuse... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune...TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited CompanyRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory MyopathyUnited States, France, Germany, Italy, Belgium, Spain
-
Seoul National University HospitalKorea Health Industry Development Institute; Dong-A University; Inha University... and other collaboratorsNot yet recruitingHospital Rapid Response Team | Hospital Medical Emergency Team
-
Advantage Silver Dental Arrest, LLCUniversity of Washington; Universidad Nacional Del Altiplano PunoCompleted
-
Fred Hutchinson Cancer CenterThe Leukemia and Lymphoma Society; Juno Therapeutics, Inc., a Bristol-Myers...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Aarhus University HospitalSheba Medical Center; Mansoura University; Eloy Espin, Department of Surgery,... and other collaboratorsUnknownQuality of Life | Rectal Neoplasms | Colostomy StomaDenmark
-
WHO Collaborating Centre for Maternal and Child...National Institute of Public Health, Slovenia; IRCCS Burlo Garofolo; University... and other collaboratorsEnrolling by invitationQuality of Care During ChildbirthItaly